Form 4: Director Louise Francesconi Reports Stock Transaction in Accelerate Diagnostics, Inc.
SEC Form 4 Filing
Director Louise Francesconi reported the vesting of restricted stock units in Accelerate Diagnostics, Inc. on June 28, 2024.
Summary
- On June 28, 2024, Louise Francesconi, a director of Accelerate Diagnostics, Inc., had 4,737 restricted stock units (RSUs) vest.
- These RSUs were part of a grant of 23,684 RSUs awarded on June 28, 2023, which vest in five equal annual installments.
- Following the transaction, Francesconi directly owns 33,558 shares of common stock and 18,947 RSUs.
- The transaction was reported on Form 4, filed with the SEC on July 1, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting scheduled vesting of previously granted stock options. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and is typical for publicly traded companies.
Stakeholder Impact
- The vesting of RSUs may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| June 28, 2023 | Reporting person was granted a total of 23,684 RSUs |
| June 28, 2024 | 4,737 Restricted Stock Units vested |
| July 01, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.